Prof. Dr. Mehmet Ali Vardar
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Ovarian Neoplasms 20 publicationsSource: OpenAlex / PubMed MeSHView publications
- Endometrial Neoplasms 18 publications
- Uterine Neoplasms 9 publications
- Carcinoma, Endometrioid 7 publications
- Carcinoma, Ovarian Epithelial 7 publications
- Peritoneal Neoplasms 6 publications
- Neoplasms, Glandular and Epithelial 6 publications
- Fallopian Tube Neoplasms 3 publications
- Uterine Cervical Neoplasms 3 publications
- Adenocarcinoma 3 publications
- Carcinosarcoma 2 publications
- Carcinoma, Squamous Cell 2 publications
- Leiomyosarcoma 2 publications
- Endometriosis 2 publications
- Trophoblastic Neoplasms 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Myom
- Robotik Cerrahi
- Adet Öncesi Gerginlik (PMS)
- Cinsel Yolla Bulaşan Hastalıklar
- Çikolata Kisti (Endometriozis) Tedavisi
- Fertilite
- Histerektomi
- HPV
- Menopoz
- Pelvik Ağrı ve Fonksiyon Bozuklukları Tedavisi
- Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
- Rahim Sarkması
- Ürojinekoloji
CV
Education and experience
Experience
- 2009Acıbadem Sağlık Grubuacibadem.com.tr
- 2001 - 2011Çukurova Üniversitesi Tıp Fakültesi / Profesöracibadem.com.tr
- 1996 - 2001Çukurova Üniversitesi Tıp Fakültesi / Doçentacibadem.com.tr
- 1992 - 1996Çukurova Üniversitesi Tıp Fakültesi / Yardımcı Doçentacibadem.com.tr
- 1991 - 1992Çukurova Üniversitesi Tıp Fakültesi / Uzman Doktor Araştırma Görevlisiacibadem.com.tr
- 1987 - 1991Çukurova Üniversitesi Tıp Fakültesi / Araştırma Görevlisi Doktoracibadem.com.tr
- 1984 - 1987Türkiye Elektrik Kurumu Adana Toroslar Müessese Müdürlüğü / Pratisyen Doktoracibadem.com.tr
Education
- 2011Tıpta Uzmanlık Kurulu, Jinekolojik Onkoloji Cerrahisi, Üst Uzmanlıkacibadem.com.tr
- 2001Çukurova Üniversitesi Tıp Fakültesi / Profesör, Digeracibadem.com.tr
- 1995Çukurova Üniversitesi Tıp Fakültesi / Doçent, Digeracibadem.com.tr
- 1991Çukurova Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum, Uzmanlıkacibadem.com.tr
- 1984Hacettepe Üniversitesi Tıp Fakültesi, Tıp, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyObstetrics and Gynaecologyacibadem.com.trFrom source
- InstitutionAcıbadem Adana Hastanesiacibadem.com.trFrom source
- Area of workOvarian NeoplasmsExtracted from 20 publications · Model version —From source
- Publications158 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:45https://www.acibadem.com.tr/doktor/mehmet-ali-vardar/acibadem.com.tr
Scientific work
Publications on Ovarian Neoplasms
-
Feasibility and Concordance of a Large Language Model (ChatGPT-5) as a Clinical Decision Support Tool in Gynecologic Oncology Tumor Boards: A Blinded, Multi-Observer Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15124451 PMID 42355621 Source: OpenAlex
-
Prognostic Significance of Immune Checkpoint Markers in Prognosis of Grade 3 Endometrioid Carcinoma
Medicina, 2026
DOI 10.3390/medicina62020327 PMID 41752726 Open-access full textSource: OpenAlex
-
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes
International Journal of Gynecological Cancer, 2026
DOI 10.1016/j.ijgc.2026.104693 PMID 42167105 Source: OpenAlex
-
Feasibility and concordance of a large language model (ChatGPT-5) as a clinical decision support tool in gynecologic oncology tumor boards: A blinded, multi-observer study.
Journal of Clinical Oncology, 2026
DOI 10.1200/jco.2026.44.16_suppl.5519 Source: OpenAlex
-
Prognostic Implications of Combined p53 and Mismatch-Repair Immunophenotypes in Uterine Carcinosarcoma
Medicina, 2026
DOI 10.3390/medicina62061135 PMID 42356147 Source: OpenAlex
-
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer
Annals of Oncology, 2025
DOI 10.1016/j.annonc.2025.11.020 PMID 41380962 6 citations (Europe PMC) Source: OpenAlex
-
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus
British journal of surgery, 2025
DOI 10.1093/bjs/znaf112 PMID 40560098 12 citations (Europe PMC) Source: OpenAlex
-
LBA44 Durvalumab + paclitaxel/carboplatin + bevacizumab followed by durvalumab, bevacizumab + olaparib maintenance in patients with newly diagnosed non-tBRCA-mutated advanced ovarian cancer: Final overall survival from DUO-O/ENGOT-ov46/GOG-3025
Annals of Oncology, 2025
DOI 10.1016/j.annonc.2025.09.056 Source: OpenAlex
-
Molecular Classification Of Serous And Clear Cell Endometrial Adenocarcinoma
International Journal of Gynecological Cancer, 2025
DOI 10.1016/j.ijgc.2024.100672 Source: OpenAlex
-
Molecular Classification And Clinical Significance In Grade 3 Endometrial Adenocarcinoma
International Journal of Gynecological Cancer, 2025
DOI 10.1016/j.ijgc.2024.100671 Source: OpenAlex